• 3rd Floor,Sreenidhi Pearls, Block–B, Plot no 12, Street No 1, Patrika Nagar, Madhapur, Hyderabad
  • info@e-itg.com
  • Office Hours: 09:00 AM - 07:00 PM

Electronic Performance Outcome (e-PerfO)

GAJA e-PerfO(Globally Accessible e-PerfO with Justified Accuracy) is a digital method of capturing objective performance-based assessments in clinical trials. It measures a patient’s functional abilities (e.g., walking speed, grip strength, memory tasks) using standardized electronic tools and sensors..

Why Choose GAJA e-PerfO for Your Clinical Trials?
  • Real-Time Data Capture Instantly collect patient-reported outcomes for accurate and timely insights.
  • Patient-Centric Design Intuitive interface improves patient compliance and engagement.
  • Regulatory Compliance Fully adheres to FDA, EMA, ICH-GCP, and GDPR standards for clinical trials.
  • Global Accessibility Supports multiple devices and languages for diverse patient populations.
  • Secure & Reliable Ensures patient data privacy with encrypted storage and secure access.
Features Of GAJA e-PerfO
  • Patient-Reported Outcomes Collect PRO data directly from patients to measure quality of life and symptoms.
  • Multi-Device Support Patients can submit outcomes via smartphone, tablet, or web browser.
  • Automated Reminders Improves compliance with scheduled alerts for pending questionnaires.
  • Multilingual Support Enables participation in global trials with multiple language options.
  • Customizable Questionnaires Design surveys tailored to study requirements and patient populations.
  • Offline Data Entry Patients can enter data offline; it syncs automatically when online.
Benefits of GAJA e-PerfO

Improved Data Accuracy

Electronic capture minimizes errors and missing entries compared to paper-based reporting.

Higher Patient Engagement

User-friendly design and reminders boost compliance and consistent participation.

Real-Time Insights

Instant access to patient-reported outcomes enables quicker decision-making.

Global Scalability

Supports multi-site, multi-language, and multi-device studies for worldwide trials.